Mitochondrial DNA mutations and breast tumorigenesis

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1836, Issue 2, 2013, Pages 336-344

  Yadav, Neelu ^a   Chandra, Dhyan ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Homoplasmy and heteroplasmy; Mitochondrial DNA; MtDNA mutations; OXPHOS; Warburg effect

Indexed keywords

MITOCHONDRIAL DNA;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER PROGNOSIS; CANCER RISK; ENERGY METABOLISM; GENE DOSAGE; GENE MUTATION; GLYCOLYSIS; HETEROPLASMY; HOMOPLASMY; HUMAN; MITOCHONDRIAL GENE; MUTATIONAL ANALYSIS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION;

BREAST CANCER; HOMOPLASMY AND HETEROPLASMY; MITOCHONDRIAL DNA; MTDNA MUTATIONS; OXPHOS; WARBURG EFFECT;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MUTATION; OXIDATIVE PHOSPHORYLATION;

EID: 84887565780     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2013.10.002     Document Type: Review

References (176)

1. American Cancer Society Cancer: Facts and Figures 2013.
2. Welcsh P.L., King M.C. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet. 2001, 10:705-713.
3. Foulkes W.D., Narod S.A. Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing. Clin. Invest. Med. 1995, 18:473-483.
4. Walsh T., Casadei S., Coats K.H., Swisher E., Stray S.M., Higgins J., Roach K.C., Mandell J., Lee M.K., Ciernikova S., Foretova L., Soucek P., King M.C. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 2006, 295:1379-1388.
5. Chen P.L., Chen C.F., Chen Y., Guo X.E., Huang C.K., Shew J.Y., Reddick R.L., Wallace D.C., Lee W.H. Mitochondrial genome instability resulting from SUV3 haploinsufficiency leads to tumorigenesis and shortened lifespan. Oncogene 2013, 32:1193-1201.
6. Kamarajugadda S., Stemboroski L., Cai Q., Simpson N.E., Nayak S., Tan M., Lu J. Glucose oxidation modulates anoikis and tumor metastasis. Mol. Cell. Biol. 2012, 32:1893-1907.
7. Mullen A.R., Wheaton W.W., Jin E.S., Chen P.H., Sullivan L.B., Cheng T., Yang Y., Linehan W.M., Chandel N.S., DeBerardinis R.J. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2012, 481:385-388.
8. Metallo C.M., Gameiro P.A., Bell E.L., Mattaini K.R., Yang J., Hiller K., Jewell C.M., Johnson Z.R., Irvine D.J., Guarente L., Kelleher J.K., Vander Heiden M.G., Iliopoulos O., Stephanopoulos G. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 2012, 481:380-384.
9. Putignani L., Raffa S., Pescosolido R., Rizza T., Del Chierico F., Leone L., Aimati L., Signore F., Carrozzo R., Callea F., Torrisi M.R., Grammatico P. Preliminary evidences on mitochondrial injury and impaired oxidative metabolism in breast cancer. Mitochondrion 2012, 12:363-369.
10. Cook C.C., Kim A., Terao S., Gotoh A., Higuchi M. Consumption of oxygen: a mitochondrial-generated progression signal of advanced cancer. Cell Death Dis. 2012, 3:e258.
11. Owens K.M., Kulawiec M., Desouki M.M., Vanniarajan A., Singh K.K. Impaired OXPHOS complex III in breast cancer. PloS One 2011, 6:e23846.
12. Sayeed A., Meng Z., Luciani G., Chen L.C., Bennington J.L., Dairkee S.H. Negative regulation of UCP2 by TGFβ signaling characterizes low and intermediate-grade primary breast cancer. Cell Death Dis. 2010, 1:e53.
13. Kaipparettu B.A., Ma Y., Wong L.J. Functional effects of cancer mitochondria on energy metabolism and tumorigenesis: utility of transmitochondrial cybrids. Ann. N. Y. Acad. Sci. 2010, 1201:137-146.
14. Kim H.S., Patel K., Muldoon-Jacobs K., Bisht K.S., Aykin-Burns N., Pennington J.D., van der Meer R., Nguyen P., Savage J., Owens K.M., Vassilopoulos A., Ozden O., Park S.H., Singh K.K., Abdulkadir S.A., Spitz D.R., Deng C.X., Gius D. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010, 17:41-52.
15. Solazzo M., Fantappie O., D'Amico M., Sassoli C., Tani A., Cipriani G., Bogani C., Formigli L., Mazzanti R. Mitochondrial expression and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines. Cancer Res. 2009, 69:7235-7242.
16. Ma Y., Bai R.K., Trieu R., Wong L.J. Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids. Biochim. Biophys. Acta 2010, 1797:29-37.
17. Shen L., Wei J., Chen T., He J., Qu J., He X., Jiang L., Qu Y., Fang H., Chen G., Lu J., Bai Y. Evaluating mitochondrial DNA in patients with breast cancer and benign breast disease. J. Cancer Res. Clin. Oncol. 2011, 137:669-675.
18. Singh K.K., Ayyasamy V., Owens K.M., Koul M.S., Vujcic M. Mutations in mitochondrial DNA polymerase-gamma promote breast tumorigenesis. J. Hum. Genet. 2009, 54:516-524.
19. Yu M., Shi Y., Wei X., Yang Y., Zang F., Niu R. Mitochondrial DNA depletion promotes impaired oxidative status and adaptive resistance to apoptosis in T47D breast cancer cells. Eur. J. Cancer Prev. 2009, 18:445-457.
20. Kulawiec M., Owens K.M., Singh K.K. Cancer cell mitochondria confer apoptosis resistance and promote metastasis. Cancer Biol. Ther. 2009, 8:1378-1385.
21. Gochhait S., Bhatt A., Sharma S., Singh Y.P., Gupta P., Bamezai R.N. Concomitant presence of mutations in mitochondrial genome and p53 in cancer development - a study in north Indian sporadic breast and esophageal cancer patients. Int. J. Cancer 2008, 123:2580-2586.
22. Darvishi K., Sharma S., Bhat A.K., Rai E., Bamezai R.N. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett. 2007, 249:249-255.
23. Tan D.J., Bai R.K., Wong L.J. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002, 62:972-976.
24. Hofhaus G., Gattermann N. Mitochondria harbouring mutant mtDNA: a cuckoo in the nest?. Biol. Chem. 1999, 380:871-877.
25. Brandon M., Baldi P., Wallace D.C. Mitochondrial mutations in cancer. Oncogene 2006, 25:4647-4662.
26. Moreno-Sanchez R., Rodriguez-Enriquez S., Marin-Hernandez A., Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007, 274:1393-1418.
27. Seyfried T.N., Shelton L.M. Cancer as a metabolic disease. Nutr. Metab. 2010, 7:7.
28. Poyton R.O., McEwen J.E. Crosstalk between nuclear and mitochondrial genomes. Annu. Rev. Biochem. 1996, 65:563-607.
29. Koopman W.J., Distelmaier F., Smeitink J.A., Willems P.H. OXPHOS mutations and neurodegeneration. EMBO J. 2013, 32:9-29.
30. Chandra D., Singh K.K. Genetic insights into OXPHOS defect and its role in cancer. Biochim. Biophys. Acta 2011, 1807:620-625.
31. Balsa E., Marco R., Perales-Clemente E., Szklarczyk R., Calvo E., Landazuri M.O., Enriquez J.A. NDUFA4 is a subunit of complex IV of the mammalian electron transport chain. Cell Metab. 2012, 16:378-386.
32. Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H., Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger F., Schreier P.H., Smith A.J., Staden R., Young I.G. Sequence and organization of the human mitochondrial genome. Nature 1981, 290:457-465.
33. Canter J.A., Kallianpur A.R., Parl F.F., Millikan R.C. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 2005, 65:8028-8033.
34. Liu V.W., Wang Y., Yang H.J., Tsang P.C., Ng T.Y., Wong L.C., Nagley P., Ngan H.Y. Mitochondrial DNA variant 16189T>C is associated with susceptibility to endometrial cancer. Hum. Mutat. 2003, 22:173-174.
35. Herrmann P.C., Gillespie J.W., Charboneau L., Bichsel V.E., Paweletz C.P., Calvert V.S., Kohn E.C., Emmert-Buck M.R., Liotta L.A., Petricoin E.F. Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics 2003, 3:1801-1810.
36. Krieg R.C., Knuechel R., Schiffmann E., Liotta L.A., Petricoin E.F., Herrmann P.C. Mitochondrial proteome: cancer-altered metabolism associated with cytochrome c oxidase subunit level variation. Proteomics 2004, 4:2789-2795.
37. Gomez-Zaera M., Abril J., Gonzalez L., Aguilo F., Condom E., Nadal M., Nunes V. Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients. Mutat. Res. 2006, 595:42-51.
38. Yin P.H., Wu C.C., Lin J.C., Chi C.W., Wei Y.H., Lee H.C. Somatic mutations of mitochondrial genome in hepatocellular carcinoma. Mitochondrion 2010, 10:174-182.
39. Tzen C.Y., Mau B.L., Wu T.Y. ND4 mutation in transitional cell carcinoma: does mitochondrial mutation occur before tumorigenesis?. Mitochondrion 2007, 7:273-278.
40. Petros J.A., Baumann A.K., Ruiz-Pesini E., Amin M.B., Sun C.Q., Hall J., Lim S., Issa M.M., Flanders W.D., Hosseini S.H., Marshall F.F., Wallace D.C. mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:719-724.
41. Wallace D.C. Mitochondria and cancer: Warburg addressed. Cold Spring Harb. Symp. Quant. Biol. 2005, 70:363-374.
42. Clayton D.A. Transcription and replication of mitochondrial DNA. Hum. Reprod. 2000, 15(Suppl. 2):11-17.
43. Arnberg A., van Bruggen E.F., Borst P. The presence of DNA molecules with a displacement loop in standard mitochondrial DNA preparations. Biochim. Biophys. Acta 1971, 246:353-357.
44. Kasamatsu H., Robberson D.L., Vinograd J. A novel closed-circular mitochondrial DNA with properties of a replicating intermediate. Proc. Natl. Acad. Sci. U. S. A. 1971, 68:2252-2257.
45. Higuchi M. Regulation of mitochondrial DNA content and cancer. Mitochondrion 2007, 7:53-57.
46. Chen X.J., Butow R.A. The organization and inheritance of the mitochondrial genome. Nat. Rev. Genet. 2005, 6:815-825.
47. He J., Mao C.C., Reyes A., Sembongi H., Di Re M., Granycome C., Clippingdale A.B., Fearnley I.M., Harbour M., Robinson A.J., Reichelt S., Spelbrink J.N., Walker J.E., Holt I.J. The AAA+ protein ATAD3 has displacement loop binding properties and is involved in mitochondrial nucleoid organization. J. Cell Biol. 2007, 176:141-146.
48. Alam T.I., Kanki T., Muta T., Ukaji K., Abe Y., Nakayama H., Takio K., Hamasaki N., Kang D. Human mitochondrial DNA is packaged with TFAM. Nucleic Acids Res. 2003, 31:1640-1645.
49. Spelbrink J.N., Li F.Y., Tiranti V., Nikali K., Yuan Q.P., Tariq M., Wanrooij S., Garrido N., Comi G., Morandi L., Santoro L., Toscano A., Fabrizi G.M., Somer H., Croxen R., Beeson D., Poulton J., Suomalainen A., Jacobs H.T., Zeviani M., Larsson C. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat. Genet. 2001, 28:223-231.
50. Garrido N., Griparic L., Jokitalo E., Wartiovaara J., van der Bliek A.M., Spelbrink J.N. Composition and dynamics of human mitochondrial nucleoids. Mol. Biol. Cell 2003, 14:1583-1596.
51. Woo D.K., Green P.D., Santos J.H., D'Souza A.D., Walther Z., Martin W.D., Christian B.E., Chandel N.S., Shadel G.S. Mitochondrial genome instability and ROS enhance intestinal tumorigenesis in APC(Min/+) mice. Am. J. Pathol. 2012, 180:24-31.
52. Benny Abraham Kaipparettu Y.M., Park Junhyoung, Lee Tin-Lap, Zhang Yiqun, Patricia Yotnda C.J.C., Chan Wai-Yee, Wong Lee-Jun C. Cross talk from noncancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways. PloS One 2013, 8:e61747.
53. Bogenhagen D.F., Wang Y., Shen E.L., Kobayashi R. Protein components of mitochondrial DNA nucleoids in higher eukaryotes. Mol. Cell. Proteomics 2003, 2:1205-1216.
54. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
55. Warburg O., Wind F., Negelein E. The metabolism of tumors in the body. J. Gen. Physiol. 1927, 8:519-530.
56. Wu M., Neilson A., Swift A.L., Moran R., Tamagnine J., Parslow D., Armistead S., Lemire K., Orrell J., Teich J., Chomicz S., Ferrick D.A. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am. J. Physiol. Cell Physiol. 2007, 292:C125-C136.
57. Guppy M., Leedman P., Zu X., Russell V. Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem. J. 2002, 364:309-315.
58. Nakashima R.A., Paggi M.G., Pedersen P.L. Contributions of glycolysis and oxidative phosphorylation to adenosine 5'-triphosphate production in AS-30D hepatoma cells. Cancer Res. 1984, 44:5702-5706.
59. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 2004, 4:891-899.
60. Zu X.L., Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem. Biophys. Res. Commun. 2004, 313:459-465.
61. Guillaumond F., Leca J., Olivares O., Lavaut M.N., Vidal N., Berthezene P., Dusetti N.J., Loncle C., Calvo E., Turrini O., Iovanna J.L., Tomasini R., Vasseur S. Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:3919-3924.
62. Chiche J., Brahimi-Horn M.C., Pouyssegur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J. Cell. Mol. Med. 2010, 14:771-794.
63. Le A., Lane A.N., Hamaker M., Bose S., Gouw A., Barbi J., Tsukamoto T., Rojas C.J., Slusher B.S., Zhang H., Zimmerman L.J., Liebler D.C., Slebos R.J., Lorkiewicz P.K., Higashi R.M., Fan T.W., Dang C.V. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 2012, 15:110-121.
64. Nakajima E.C., Van Houten B. Metabolic symbiosis in cancer: refocusing the Warburg lens. Mol. Carcinog. 2013, 52:329-337.
65. Zhou Y., Zhou Y., Shingu T., Feng L., Chen Z., Ogasawara M., Keating M.J., Kondo S., Huang P. Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis. J. Biol. Chem. 2011, 286:32843-32853.
66. Polyak K., Li Y., Zhu H., Lengauer C., Willson J.K., Markowitz S.D., Trush M.A., Kinzler K.W., Vogelstein B. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet. 1998, 20:291-293.
67. Fliss M.S., Usadel H., Caballero O.L., Wu L., Buta M.R., Eleff S.M., Jen J., Sidransky D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000, 287:2017-2019.
68. Schon E.A., DiMauro S., Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat. Rev. Genet. 2012, 13:878-890.
69. Yu M. Somatic mitochondrial DNA mutations in human cancers. Adv. Clin. Chem. 2012, 57:99-138.
70. Boultwood J., Fidler C., Mills K.I., Frodsham P.M., Kusec R., Gaiger A., Gale R.E., Linch D.C., Littlewood T.J., Moss P.A., Wainscoat J.S. Amplification of mitochondrial DNA in acute myeloid leukaemia. Br. J. Haematol. 1996, 95:426-431.
71. Liu V.W., Shi H.H., Cheung A.N., Chiu P.M., Leung T.W., Nagley P., Wong L.C., Ngan H.Y. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res. 2001, 61:5998-6001.
72. Nagy A., Wilhelm M., Sukosd F., Ljungberg B., Kovacs G. Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas. Genes Chromosomes Cancer 2002, 35:256-260.
73. Chatterjee A., Mambo E., Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene 2006, 25:4663-4674.
74. Debniak T., Scott R.J., Huzarski T., Byrski T., Masojc B., van de Wetering T., Serrano-Fernandez P., Gorski B., Cybulski C., Gronwald J., Debniak B., Maleszka R., Kladny J., Bieniek A., Nagay L., Haus O., Grzybowska E., Wandzel P., Niepsuj S., Narod S.A., Lubinski J. XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res. Treat. 2006, 98:209-215.
75. Shen J., Platek M., Mahasneh A., Ambrosone C.B., Zhao H. Mitochondrial copy number and risk of breast cancer: a pilot study. Mitochondrion 2010, 10:62-68.
76. Alhomidi M.A., Vedicherla B., Movva S., Rao P.K., Ahuja Y.R., Hasan Q. Mitochondrial D310 instability in Asian Indian breast cancer patients. Tumour Biol. 2013, 34:2427-2432.
77. Imanishi H., Hattori K., Wada R., Ishikawa K., Fukuda S., Takenaga K., Nakada K., Hayashi J. Mitochondrial DNA mutations regulate metastasis of human breast cancer cells. PloS One 2011, 6:e23401.
78. Bai R.K., Leal S.M., Covarrubias D., Liu A., Wong L.J. Mitochondrial genetic background modifies breast cancer risk. Cancer Res. 2007, 67:4687-4694.
79. Tipirisetti N.R., Lakshmi R.K., Govatati S., Govatati S., Vuree S., Singh L., Raghunadha Rao D., Bhanoori M., Vishnupriya S. Mitochondrial genome variations in advanced stage breast cancer: a case-control study. Mitochondrion 2013, 13:372-378.
80. Ye C., Shu X.O., Pierce L., Wen W., Courtney R., Gao Y.T., Zheng W., Cai Q. Mutations in the mitochondrial DNA D-loop region and breast cancer risk. Breast Cancer Res. Treat. 2010, 119:431-436.
81. Cai F.F., Kohler C., Zhang B., Chen W.J., Barekati Z., Garritsen H.S., Lenner P., Toniolo P., Zhang J.J., Zhong X.Y. Mutations of mitochondrial DNA as potential biomarkers in breast cancer. Anticancer Res. 2011, 31:4267-4271.
82. Yu M., Zhou Y., Shi Y., Ning L., Yang Y., Wei X., Zhang N., Hao X., Niu R. Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients. IUBMB Life 2007, 59:450-457.
83. Tseng L.M., Yin P.H., Yang C.W., Tsai Y.F., Hsu C.Y., Chi C.W., Lee H.C. Somatic mutations of the mitochondrial genome in human breast cancers. Genes Chromosomes Cancer 2011, 50:800-811.
84. Kulawiec M., Safina A., Desouki M.M., Still I., Matsui S., Bakin A., Singh K.K. Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion. Cancer Biol. Ther. 2008, 7:1732-1743.
85. Alhomidi M.A., Vedicherla B., Movva S., Rao P.K., Ahuja Y.R., Hasan Q. Mitochondrial D310 instability in Asian Indian breast cancer patients. Tumour Biol. 2013, 34:2427-2432.
86. Bai R.K., Chang J., Yeh K.T., Lou M.A., Lu J.F., Tan D.J., Liu H., Wong L.J. Mitochondrial DNA content varies with pathological characteristics of breast cancer. J. Oncol. 2011, 2011:496189.
87. Czarnecka A.M., Krawczyk T., Plak K., Klemba A., Zdrozny M., Arnold R.S., Kofler B., Golik P., Szybinska A., Lubinski J., Mossakowska M., Bartnik E., Petros J.A. Mitochondrial genotype and breast cancer predisposition. Oncol. Rep. 2010, 24:1521-1534.
88. De Vitto H., Mendonca B.S., Elseth K.M., Vesper B.J., Portari E.A., Gallo C.V., Paradise W.A., Rumjanek F.D., Radosevich J.A. Part II. Mitochondrial mutational status of high nitric oxide adapted cell line BT-20 (BT-20-HNO) as it relates to human primary breast tumors. Tumour Biol. 2013, 34:337-347.
89. Fang H., Shen L., Chen T., He J., Ding Z., Wei J., Qu J., Chen G., Lu J., Bai Y. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer 2010, 10:421.
90. Gutierrez Povedano C., Salgado J., Gil C., Robles M., Patino-Garcia A., Garcia-Foncillas J. Analysis of BRCA1 and mtDNA haplotypes and mtDNA polymorphism in familial breast cancer. Mitochondrial DNA 2013, (in press).
91. Kuo S.J., Chen M., Ma G.C., Chen S.T., Chang S.P., Lin W.Y., Chen Y.C., Lee T.H., Lin T.T., Liu C.S. Number of somatic mutations in the mitochondrial D-loop region indicates poor prognosis in breast cancer, independent of TP53 mutation. Cancer Genet. Cytogenet. 2010, 201:94-101.
92. Nie H., Shu H., Vartak R., Milstein A.C., Mo Y., Hu X., Fang H., Shen L., Ding Z., Lu J., Bai Y. Mitochondrial common deletion, a potential biomarker for cancer occurrence, is selected against in cancer background: a meta-analysis of 38 studies. PloS One 2013, 8:e67953.
93. Rahmani B., Azimi C., Omranipour R., Raoofian R., Zendehdel K., Saee-Rad S., Heidari M. Mutation screening in the mitochondrial D-loop region of tumoral and non-tumoral breast cancer in Iranian patients. Acta Med. Iran. 2012, 50:447-453.
94. Rohan T.E., Wong L.J., Wang T., Haines J., Kabat G.C. Do alterations in mitochondrial DNA play a role in breast carcinogenesis?. J. Oncol. 2010, 2010:604304.
95. Sultana G.N., Rahman A., Shahinuzzaman A.D., Begum R.A., Hossain C.F. Mitochondrial DNA mutations-candidate biomarkers for breast cancer diagnosis in Bangladesh. Chin. J.Cancer 2012, 31:449-454.
96. Tengku Baharudin N., Jaafar H., Zainuddin Z. Association of mitochondrial DNA 10398 polymorphism in invasive breast cancer in Malay population of Peninsular Malaysia. Malays. J. Med. Sci. 2012, 19:36-42.
97. Thyagarajan B., Wang R., Nelson H., Barcelo H., Koh W.P., Yuan J.M. Mitochondrial DNA copy number is associated with breast cancer risk. PloS One 2013, 8:e65968.
98. Tipirisetti N.R., Lakshmi R.K., Govatati S., Govatati S., Vuree S., Singh L., Raghunadha Rao D., Bhanoori M., Vishnupriya S. Mitochondrial genome variations in advanced stage breast cancer: a case-control study. Mitochondrion 2013, 13:372-378.
99. Xu C., Tran-Thanh D., Ma C., May K., Jung J., Vecchiarelli J., Done S.J. Mitochondrial D310 mutations in the early development of breast cancer. Br. J. Cancer 2012, 106:1506-1511.
100. Zhu W., Qin W., Bradley P., Wessel A., Puckett C.L., Sauter E.R. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis 2005, 26:145-152.
101. Tseng L.M., Yin P.H., Chi C.W., Hsu C.Y., Wu C.W., Lee L.M., Wei Y.H., Lee H.C. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer 2006, 45:629-638.
102. Grzybowska-Szatkowska L., Slaska B. Polymorphisms in genes encoding mt-tRNA in female breast cancer in Poland. Mitochondrial DNA 2012, 23:106-111.
103. Santidrian A.F., Matsuno-Yagi A., Ritland M., Seo B.B., LeBoeuf S.E., Gay L.J., Yagi T., Felding-Habermann B. Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J. Clin. Investig. 2013, 123:1068-1081.
104. Cerutti P.A. Prooxidant states and tumor promotion. Science 1985, 227:375-381.
105. Kulawiec M., Ayyasamy V., Singh K.K. p53 regulates mtDNA copy number and mitocheckpoint pathway. J. Carcinog. 2009, 8:8.
106. Singh K.K. Mitochondria damage checkpoint, aging, and cancer. Ann. N. Y. Acad. Sci. 2006, 1067:182-190.
107. Kaipparettu B.A., Ma Y., Park J.H., Lee T.L., Zhang Y., Yotnda P., Creighton C.J., Chan W.Y., Wong L.J. Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways. PloS One 2013, 8:e61747.
108. Wallace D.C. Mitochondria and cancer. Nat. Rev. Cancer 2012, 12:685-698.
109. Desouki M.M., Kulawiec M., Bansal S., Das G.M., Singh K.K. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol. Ther. 2005, 4:1367-1373.
110. Singh K.K., Kulawiec M., Still I., Desouki M.M., Geradts J., Matsui S. Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 2005, 354:140-146.
111. Kulawiec M., Arnouk H., Desouki M.M., Kazim L., Still I., Singh K.K. Proteomic analysis of mitochondria-to-nucleus retrograde response in human cancer. Cancer Biol. Ther. 2006, 5:967-975.
112. Lu J., Sharma L.K., Bai Y. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res. 2009, 19:802-815.
113. Chatterjee A., Dasgupta S., Sidransky D. Mitochondrial subversion in cancer. Cancer Prev. Res. (Phila.) 2011, 4:638-654.
114. Wang Y., Liu V.W., Tsang P.C., Chiu P.M., Cheung A.N., Khoo U.S., Nagley P., Ngan H.Y. Microsatellite instability in mitochondrial genome of common female cancers. Int. J. Gynecol. Cancer 2006, 16(Suppl. 1):259-266.
115. Hall I.J., Moorman P.G., Millikan R.C., Newman B. Comparative analysis of breast cancer risk factors among African-American women and White women. Am. J. Epidemiol. 2005, 161:40-51.
116. Setiawan V.W., Chu L.H., John E.M., Ding Y.C., Ingles S.A., Bernstein L., Press M.F., Ursin G., Haiman C.A., Neuhausen S.L. Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women. Cancer Genet. Cytogenet. 2008, 181:16-19.
117. Francis A., Pooja S., Rajender S., Govindaraj P., Tipirisetti N.R., Surekha D., Rao D.R., Rao L., Ramachandra L., Vishnupriya S., Ramalingam K., Satyamoorthy K., Thangaraj K. A mitochondrial DNA variant 10398G>A in breast cancer among South Indians: an original study with meta-analysis. Mitochondrion 2013, 13:559-565.
118. Czarnecka A.M., Krawczyk T., Zdrozny M., Lubinski J., Arnold R.S., Kukwa W., Scinska A., Golik P., Bartnik E., Petros J.A. Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res. Treat. 2010, 121:511-518.
119. Covarrubias D., Bai R.K., Wong L.J., Leal S.M. Mitochondrial DNA variant interactions modify breast cancer risk. J. Hum. Genet. 2008, 53:924-928.
120. Pezzotti A., Kraft P., Hankinson S.E., Hunter D.J., Buring J., Cox D.G. The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk. PloS One 2009, 4:e5356.
121. Bhat A., Koul A., Sharma S., Rai E., Bukhari S.I., Dhar M.K., Bamezai R.N. The possible role of 10398A and 16189C mtDNA variants in providing susceptibility to T2DM in two North Indian populations: a replicative study. Hum. Genet. 2007, 120:821-826.
122. Czarnecka A.M., Klemba A., Krawczyk T., Zdrozny M., Arnold R.S., Bartnik E., Petros J.A. Mitochondrial NADH-dehydrogenase polymorphisms as sporadic breast cancer risk factor. Oncol. Rep. 2010, 23:531-535.
123. Fendt L., Niederstatter H., Huber G., Zelger B., Dunser M., Seifarth C., Rock A., Schafer G., Klocker H., Parson W. Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection. Breast Cancer Res. Treat. 2011, 128:327-336.
124. Barekati Z., Radpour R., Kohler C., Zhang B., Toniolo P., Lenner P., Lv Q., Zheng H., Zhong X.Y. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations. Hum. Mol. Genet. 2010, 19:2936-2946.
125. Platek M.E., Shields P.G., Tan D., Marian C., Bonner M.R., McCann S.E., Nie J., Wilding G.E., Ambrosone C., Millen A.E., Trevisan M., Russell M., Nochajski T.H., Edge S.B., Winston J., Freudenheim J.L. Alcohol consumption and breast tumor mitochondrial DNA mutations. Breast Cancer Res. Treat. 2010, 121:453-460.
126. Wang C.Y., Wang H.W., Yao Y.G., Kong Q.P., Zhang Y.P. Somatic mutations of mitochondrial genome in early stage breast cancer. Int. J. Cancer 2007, 121:1253-1256.
127. Parrella P., Xiao Y., Fliss M., Sanchez-Cespedes M., Mazzarelli P., Rinaldi M., Nicol T., Gabrielson E., Cuomo C., Cohen D., Pandit S., Spencer M., Rabitti C., Fazio V.M., Sidransky D. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 2001, 61:7623-7626.
128. Barekati Z., Radpour R., Kohler C., Zhang B., Toniolo P., Lenner P., Lv Q., Zheng H., Zhong X.Y. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations, Hum. Mol. Genet. 2010, 19:2936-2946.
129. Jakupciak J.P., Dakubo G.D., Maragh S., Parr R.L. Analysis of potential cancer biomarkers in mitochondrial DNA. Curr. Opin. Mol. Ther. 2006, 8:500-506.
130. Zhu W., Qin W., Sauter E.R. Large-scale mitochondrial DNA deletion mutations and nuclear genome instability in human breast cancer. Cancer Detect. Prev. 2004, 28:119-126.
131. Ye C., Shu X.O., Pierce L., Wen W., Courtney R., Gao Y.T., Zheng W., Cai Q. Mutations in the mitochondrial DNA D-loop region and breast cancer risk, Breast Cancer Res. Treat. 2010, 119:431-436.
132. Bianchi M.S., Bianchi N.O., Bailliet G. Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet. Cell Genet. 1995, 71:99-103.
133. Ye C., Shu X.O., Wen W., Pierce L., Courtney R., Gao Y.T., Zheng W., Cai Q. Quantitative analysis of mitochondrial DNA 4977-bp deletion in sporadic breast cancer and benign breast diseases. Breast Cancer Res. Treat. 2008, 108:427-434.
134. Maggrah A., Robinson K., Creed J., Wittock R., Gehman K., Gehman T., Brown H., Harbottle A., Froberg M.K., Klein D., Reguly B., Parr R. Paired ductal carcinoma in situ and invasive breast cancer lesions in the D-loop of the mitochondrial genome indicate a cancerization field effect. Biomed. Res. Int. 2013, 2013:379438.
135. Jakupciak J.P., Maggrah A., Maragh S., Maki J., Reguly B., Maki K., Wittock R., Robinson K., Wagner P.D., Thayer R.E., Gehman K., Gehman T., Srivastava S., Ngom A., Dakubo G.D., Parr R.L. Facile whole mitochondrial genome resequencing from nipple aspirate fluid using MitoChip v2.0. BMC Cancer 2008, 8:95.
136. Parra M.D., Martinez de Morentin B.E., Martinez J.A. Postprandial insulin response and mitochondrial oxidation in obese men nutritionally treated to lose weight. Eur. J. Clin. Nutr. 2005, 59:334-340.
137. Isaacs C., Cavalli L.R., Cohen Y., Pennanen M., Shankar L.K., Freedman M., Singh B., Liu M., Gallagher A., Rone J.D., Dickson R.B., Sidransky D., Haddad B.R. Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patients. Breast Cancer Res. Treat. 2004, 84:99-105.
138. Yadava N., Schneider S.S., Jerry D.J., Kim C. Impaired mitochondrial metabolism and mammary carcinogenesis. J. Mammary Gland Biol. Neoplasia 2013, 18:75-87.
139. Putignani L., Raffa S., Pescosolido R., Aimati L., Signore F., Torrisi M.R., Grammatico P. Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria. Breast Cancer Res. Treat. 2008, 110:439-452.
140. Kulawiec M., Owens K.M., Singh K.K. mtDNA G10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice. J. Hum. Genet. 2009, 54:647-654.
141. Compton S., Kim C., Griner N.B., Potluri P., Scheffler I.E., Sen S., Jerry D.J., Schneider S., Yadava N. Mitochondrial dysfunction impairs tumor suppressor p53 expression/function. J. Biol. Chem. 2011, 286:20297-20312.
142. Feng Z., Hu W., Teresky A.K., Hernando E., Cordon-Cardo C., Levine A.J. Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16633-16638.
143. Larman T.C., DePalma S.R., Hadjipanayis A.G., Protopopov A., Zhang J., Gabriel S.B., Chin L., Seidman C.E., Kucherlapati R., Seidman J.G. Spectrum of somatic mitochondrial mutations in five cancers. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:14087-14091.
144. Mambo E., Chatterjee A., Xing M., Tallini G., Haugen B.R., Yeung S.C., Sukumar S., Sidransky D. Tumor-specific changes in mtDNA content in human cancer. Int. J. Cancer 2005, 116:920-924.
145. Simonnet H., Alazard N., Pfeiffer K., Gallou C., Beroud C., Demont J., Bouvier R., Schagger H., Godinot C. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 2002, 23:759-768.
146. Hsu C.W., Yin P.H., Lee H.C., Chi C.W., Tseng L.M. Mitochondrial DNA content as a potential marker to predict response to anthracycline in breast cancer patients. Breast J. 2010, 16:264-270.
147. Xia P., An H.X., Dang C.X., Radpour R., Kohler C., Fokas E., Engenhart-Cabillic R., Holzgreve W., Zhong X.Y. Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer. BMC Cancer 2009, 9:454.
148. Rossignol R., Gilkerson R., Aggeler R., Yamagata K., Remington S.J., Capaldi R.A. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 2004, 64:985-993.
149. Chandra D., Liu J.W., Tang D.G. Early mitochondrial activation and cytochrome c up-regulation during apoptosis. J. Biol. Chem. 2002, 277:50842-50854.
150. Xiao D., Powolny A.A., Singh S.V. Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells. J. Biol. Chem. 2008, 283:30151-30163.
151. Fan A.X., Radpour R., Haghighi M.M., Kohler C., Xia P., Hahn S., Holzgreve W., Zhong X.Y. Mitochondrial DNA content in paired normal and cancerous breast tissue samples from patients with breast cancer. J. Cancer Res. Clin. Oncol. 2009, 135:983-989.
152. Koochekpour S., Marlowe T., Singh K.K., Attwood K., Chandra D. Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men. PloS One 2013, 8:e74688.
153. Chen J.Q., Delannoy M., Cooke C., Yager J.D. Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E1011-E1022.
154. Chen J.Q., Yager J.D., Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim. Biophys. Acta 2005, 1746:1-17.
155. Chen J.Q., Cammarata P.R., Baines C.P., Yager J.D. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim. Biophys. Acta 2009, 1793:1540-1570.
156. Yager J.D., Chen J.Q. Mitochondrial estrogen receptors-new insights into specific functions. Trends Endocrinol. Metab. 2007, 18:89-91.
157. Konduri S.D., Medisetty R., Liu W., Kaipparettu B.A., Srivastava P., Brauch H., Fritz P., Swetzig W.M., Gardner A.E., Khan S.A., Das G.M. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15081-15086.
158. Achanta G., Sasaki R., Feng L., Carew J.S., Lu W., Pelicano H., Keating M.J., Huang P. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J. 2005, 24:3482-3492.
159. Clay Montier L.L., Deng J.J., Bai Y. Number matters: control of mammalian mitochondrial DNA copy number. J. Genet. Genomics 2009, 36:125-131.
160. Clayton D.A. Replication and transcription of vertebrate mitochondrial DNA. Annu. Rev. Cell Biol. 1991, 7:453-478.
161. Saffran H.A., Pare J.M., Corcoran J.A., Weller S.K., Smiley J.R. Herpes simplex virus eliminates host mitochondrial DNA. EMBO Rep. 2007, 8:188-193.
162. Trachootham D., Zhou Y., Zhang H., Demizu Y., Chen Z., Pelicano H., Chiao P.J., Achanta G., Arlinghaus R.B., Liu J., Huang P. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 2006, 10:241-252.
163. Giles R.E., Blanc H., Cann H.M., Wallace D.C. Maternal inheritance of human mitochondrial DNA. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:6715-6719.
164. Richard S.M., Bailliet G., Paez G.L., Bianchi M.S., Peltomaki P., Bianchi N.O. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. 2000, 60:4231-4237.
165. Cavelier L., Jazin E., Jalonen P., Gyllensten U. MtDNA substitution rate and segregation of heteroplasmy in coding and noncoding regions. Hum. Genet. 2000, 107:45-50.
166. Coller H.A., Khrapko K., Bodyak N.D., Nekhaeva E., Herrero-Jimenez P., Thilly W.G. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat. Genet. 2001, 28:147-150.
167. Vega A., Salas A., Gamborino E., Sobrido M.J., Macaulay V., Carracedo A. mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations. Oncogene 2004, 23:1314-1320.
168. Shay J.W., Werbin H. Are mitochondrial DNA mutations involved in the carcinogenic process?. Mutat. Res. 1987, 186:149-160.
169. Rossignol R., Faustin B., Rocher C., Malgat M., Mazat J.P., Letellier T. Mitochondrial threshold effects. Biochem. J. 2003, 370:751-762.
170. Chauvin C., De Oliveira F., Ronot X., Mousseau M., Leverve X., Fontaine E. Rotenone inhibits the mitochondrial permeability transition-induced cell death in U937 and KB cells. J. Biol. Chem. 2001, 276:41394-41398.
171. Higuchi M., Aggarwal B.B., Yeh E.T. Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J. Clin. Investig. 1997, 99:1751-1758.
172. McClintock D.S., Santore M.T., Lee V.Y., Brunelle J., Budinger G.R., Zong W.X., Thompson C.B., Hay N., Chandel N.S. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol. Cell. Biol. 2002, 22:94-104.
173. Naviaux R.K. Oxidative shielding or oxidative stress?. J. Pharmacol. Exp. Ther. 2012, 342:608-618.
174. Andersen J.L., Kornbluth S. The tangled circuitry of metabolism and apoptosis. Mol. Cell 2013, 49:399-410.
175. Pelicano H., Xu R.H., Du M., Feng L., Sasaki R., Carew J.S., Hu Y., Ramdas L., Hu L., Keating M.J., Zhang W., Plunkett W., Huang P. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J. Cell Biol. 2006, 175:913-923.
176. Hashizume O., Shimizu A., Yokota M., Sugiyama A., Nakada K., Miyoshi H., Itami M., Ohira M., Nagase H., Takenaga K., Hayashi J. Specific mitochondrial DNA mutation in mice regulates diabetes and lymphoma development. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:10528-10533.